personalized treatments

Makary

Biotech

FDA unveils new pathway to speed custom gene editing therapies

Called the “plausible mechanism pathway,” the program is designed to offer a new way to market for personalized therapies, FDA officials said.

Angus Liu Nov 12, 2025 5:00pm

blood test tube

Invitae launches personalized blood tests to spot cancer relapse

Mar 17, 2022 10:20am

Kite CAR-T manufacturing

Vineti nets $35M to expand logistics software for cell therapy

Feb 6, 2020 9:18am

Human T cell

Pact Pharma launches a trial of its CAR-T for solid tumors

Jul 22, 2019 9:20am

AZ's Baselga on tailored treatments and the march to cure cancer

Jun 4, 2019 11:10am

Abdominal pain

Personalizing Crohn’s therapies with microRNA as marker

Oct 4, 2018 9:00am